Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gamma-delta t cells (1 trial)
tcb008 (2 trials)
allogeneic gamma-delta t cells (1 trial)
Carcinoma, Renal Cell (Phase 3)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Melanoma (Phase 3)
Trials (4 total)
Trial APIs (3 total)